
Why ATICUS Matters: Markas’ Story from Addenbrookes
Markas beat leukaemia at just 3 years old, and his story shows why the ATICUS Network is vital for giving children access to life-saving treatments.
Markas beat leukaemia at just 3 years old, and his story shows why the ATICUS Network is vital for giving children access to life-saving treatments.
On World AML Awareness Day, through continued investment in the Trials Acceleration Programme (TAP) network, Cure Leukaemia are proud to announce two major clinical trials are on the horizon, EVOLVE 1 and 2.